A Randomized Trial Of Varenicline For Smoking Cessation In Latin America, Africa And The Middle East

被引:0
|
作者
Bolliger, C. T. [1 ]
Issa, J. S. [2 ]
Posadas-Valay, R. [3 ]
Safwat, T. [4 ]
Abreu, P. [5 ]
Correia, E. A. [6 ]
Chopra, P. [5 ]
机构
[1] Univ Stellenbosch, Cape Town, South Africa
[2] Univ Sao Paulo, Sao Paulo, Brazil
[3] Hosp Univ UANL, Monterrey, Mexico
[4] Ain Shams Univ, Cairo, Egypt
[5] Pfizer Inc, New York, NY USA
[6] Pfizer Inc, Sao Paulo, Brazil
关键词
D O I
暂无
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
A2648
引用
收藏
页数:1
相关论文
共 50 条
  • [21] ADHERENCE TO VARENICLINE AS A PREDICTOR OF SMOKING CESSATION IN THE COMPASS TRIAL
    Catz, Sheryl L.
    Jack, Lisa
    McClure, Jennifer B.
    Deprey, Mona
    Zbikowski, Susan
    McAfee, Tim
    Javitz, Harold
    Gary, Swan
    ANNALS OF BEHAVIORAL MEDICINE, 2010, 39 : 192 - 192
  • [22] Adherence to Varenicline in the COMPASS Smoking Cessation Intervention Trial
    Catz, Sheryl L.
    Jack, Lisa M.
    McClure, Jennifer B.
    Javitz, Harold S.
    Deprey, Mona
    Zbikowski, Susan M.
    McAfee, Tim
    Richards, Julie
    Swan, Gary E.
    NICOTINE & TOBACCO RESEARCH, 2011, 13 (05) : 361 - 368
  • [23] Retreatment With Varenicline for Smoking Cessation in Smokers Who Have Previously Taken Varenicline: A Randomized, Placebo-Controlled Trial
    Gonzales, D.
    Hajek, P.
    Pliamm, L.
    Nackaerts, K.
    Tseng, L-J
    Mcrae, T. D.
    Treadow, J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2014, 96 (03) : 390 - 396
  • [24] Varenicline versus placebo for waterpipe smoking cessation: a double-blind randomized controlled trial
    Dogar, Omara
    Zahid, Raana
    Mansoor, Sonia
    Kanaan, Mona
    Ahluwalia, Jasjit S.
    Jawad, Mohammed
    Siddiqi, Kamran
    ADDICTION, 2018, 113 (12) : 2290 - 2299
  • [25] PSYCHIATRIC ADVERSE REACTIONS IN A PROSPECTIVE, RANDOMIZED CLINICAL TRIAL OF VARENICLINE FOR SMOKING CESSATION IN PATIENTS WITH COPD
    Zhou, W.
    Wei, X.
    Ke, H.
    RESPIROLOGY, 2011, 16 : 11 - 11
  • [26] A Randomized Placebo-Controlled Trial of Varenicline for Smoking Cessation Allowing Flexible Quit Dates
    Rennard, Stephen
    Hughes, John
    Cinciripini, Paul M.
    Kralikova, Eva
    Raupach, Tobias
    Arteaga, Carmen
    St Aubin, Lisa B.
    Russ, Cristina
    NICOTINE & TOBACCO RESEARCH, 2012, 14 (03) : 343 - 350
  • [27] Varenicline for smoking cessation: A placebo-controlled, randomized study
    Wang, Chen
    Xiao, Dan
    Chan, Kenneth Ping Wah
    Pothirat, Chaicharn
    Garza, Dahlia
    Davies, Simon
    RESPIROLOGY, 2009, 14 (03) : 384 - 392
  • [28] Effect of 0.5 mg versus 1 mg varenicline for smoking cessation: a randomized controlled trial
    Fouz-Roson, Natalia
    Montemayor-Rubio, Teodoro
    Almadana-Pacheco, Virginia
    Montserrat-Garcia, Soledad
    Paulina Gomez-Bastero, Ana
    Romero-Munoz, Concepcion
    Polo-Padillo, Juan
    ADDICTION, 2017, 112 (09) : 1610 - 1619
  • [29] A Pilot Randomized Clinical Trial of Remote Varenicline Sampling to Promote Treatment Engagement and Smoking Cessation
    Carpenter, Matthew J.
    Gray, Kevin M.
    Wahlquist, Amy E.
    Cropsey, Karen
    Saladin, Michael E.
    Froeliger, Brett
    Smith, Tracy T.
    Toll, Benjamin A.
    Dahne, Jennifer
    NICOTINE & TOBACCO RESEARCH, 2021, 23 (06) : 983 - 991
  • [30] Efficacy and Safety of Varenicline for Smoking Cessation in Patients With Type 2 Diabetes A Randomized Clinical Trial
    Russo, Cristina
    Walicka, Magdalena
    Caponnetto, Pasquale
    Cibella, Fabio
    Maglia, Marilena
    Alamo, Angela
    Campagna, Davide
    Frittitta, Lucia
    Di Mauro, Maurizio
    Caci, Grazia
    Krysinski, Arkadiusz
    Franek, Edward
    Polosa, Riccardo
    JAMA NETWORK OPEN, 2022, 5 (06) : E2217709